Envision Pharma, a global provider of evidence-based communication services and industry-leading technology solutions, completed the acquisition of 90TEN, a global healthcare communications consultancy. Financial terms were not disclosed. “We’re delighted to welcome an award-winning healthcare communications consultancy into the Envision Pharma Group family. 90TEN will add its expertise across new verticals for the group – in corporate communications and public relations, while extending Envision’s current footprint in patient engagement and medical communications with its behavioral science methodology. This move bolsters our industry-leading scientific communications capabilities, and enables us to strengthen our offering to clients across the product life cycle," David Thompson, Envision Pharma CEO.